Covered recipient · General Payments record
KELSI HOLLAND
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,051.28
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $855.76 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $372.29 | 9 |
| REVANCE THERAPEUTICS, INC. | $224.52 | 3 |
| GlaxoSmithKline, LLC. | $120.86 | 1 |
| Kerecis Limited | $60.60 | 2 |
| BIOTISSUE HOLDINGS INC. | $36.29 | 1 |
| AXOGEN | $22.43 | 1 |
| Heron Therapeutics, Inc. | $18.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.46 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348470 | CMS |
| ABBVIE INC. | $30.67 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348472 | CMS |
| ABBVIE INC. | $21.73 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348474 | CMS |
| ABBVIE INC. | $48.71 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348476 | CMS |
| ABBVIE INC. | $59.54 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348478 | CMS |
| ABBVIE INC. | $122.84 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348480 | CMS |
| ABBVIE INC. | $25.94 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348482 | CMS |
| ABBVIE INC. | $25.94 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348484 | CMS |
| ABBVIE INC. | $10.46 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107348486 | CMS |
| AXOGEN | $22.43 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143643409 | CMS |
| BIOTISSUE HOLDINGS INC. | $36.29 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148747938 | CMS |
| GlaxoSmithKline, LLC. | $120.86 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116226307 | CMS |
| Heron Therapeutics, Inc. | $18.77 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147252059 | CMS |
| Kerecis Limited | $51.32 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120095987 | CMS |
| Kerecis Limited | $9.28 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120111319 | CMS |
| REVANCE THERAPEUTICS, INC. | $99.28 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147942277 | CMS |
| REVANCE THERAPEUTICS, INC. | $16.45 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147942279 | CMS |
| REVANCE THERAPEUTICS, INC. | $108.79 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147942281 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.